REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

Go back to REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Amgen Inc (NASDAQ: AMGN) Delayed: 337.60 -4.06 (1.19%)
Previous Close $341.66    52 Week High $176.85 
Open $344.38    52 Week Low $133.64 
Day High $345.00    P/E 50.84 
Day Low $334.05    EPS $6.64 
Volume 8,250,202       

CHEMOCENTRYX (NASDAQ: CCXI) Delayed: 10.31 -0.02 (0.19%)
Previous Close $10.33    52 Week High $8.30 
Open $10.27    52 Week Low $1.92 
Day High $10.31    P/E N/A 
Day Low $10.27    EPS $-1.00 
Volume 620